New funding opportunity for your brain research!

UP TO $1.6 MILLION AVAILABLE TO SUPPORT COLLABORATIVE BRAIN RESEARCH PROJECTSBrain Canada Foundation (Brain Canada) and CQDM are joining forces to support interprovincial collaborative biopharmaceutical research and development (R&D) projects on the brain. This partnership creates a unique funding opportunity that brings together experts from academia and industry to support the development of platforms, tools and biopharmaceuticals that…

Welcome to CQDM, Maïlyn Yates!🎉

Maïlyn holds a PhD in Molecular and Cellular Biology from the Université de Sherbrooke. Her research explores DNA repair mechanisms under replicative stress to identify new therapeutic targets in oncology. She has presented her work nationally and internationally and has received multiple awards and scholarships. She also holds an MBA from IAE Poitiers. 👉 Discover…

🎉 Welcome to CQDM, Julien Dufort-Gervais!

We are pleased to welcome Julien Dufort-Gervais as a Project Manager at CQDM. With strong experience in preclinical development and fundamental research in Québec, Julien will leverage his expertise to support the biopharmaceutical innovation projects funded by the organization. Julien holds a Master’s degree in Pharmacology from Université de Montréal and has recognized expertise in…

For the first time, Connect-Bio is coming to Toronto

CQDM, in partnership with NGen, invites you to Connect-Bio | Bringing Together Canada’s Genomics Ecosystem, a flagship event uniting Canada’s genomics, life sciences, and biopharmaceutical innovation ecosystem. This Toronto edition will bring together companies and organizations active in genomics or interested in the field—from pharmaceutical companies to innovative startups and service providers, as well as…

Deux nouveaux membres rejoignent le Comité consultatif scientifique du CQDM

Quand l’intelligence artificielle redéfinit la recherche biopharmaceutique, s’entourer d’une expertise de premier plan est plus essentiel que jamais !Le CQDM est très heureux d’accueillir Radia Johnson et Artem Cherkasov au sein de son Comité consultatif scientifique. Radia Johnson est biologiste computationnelle et dirigeante en sciences de la vie, spécialisée dans la découverte de biomarqueurs et…

Welcome, Juliette Sabbatani, our new project manager

Welcome Juliette Sabbatani, our new project manager at CQDM ! 🎉 Juliette Sabbatani is an innovative scientist with nearly ten years of experience in the pharmaceutical industry and drug discovery. A co-inventor on ten patents, she has led complex projects across academic, biotech, and startup environments. 🌟 Learn more about her : Juliette Sabbatani

CQDM Funds Two Projects to Advance Preclinical Research Through the Use of Organoids

Announcement Montreal, November 20, 2025 – CQDM is proud to announce the funding of two collaborative research projects that share a common goal: reinventing preclinical research by reducing the use of in vivo testing. Valued at a total of $1,145,874, these projects are made possible through a grant from the Government of Quebec awarded by…

CQDM Invests in Three Promising Projects Offering Hope to Patients with Complex Diseases

Announcement Montreal, November 18, 2025 – CQDM is proud to announce funding for three collaborative research projects, each driven by a shared ambition: to advance therapeutic innovation and improve treatment options for complex diseases, including rare genetic disorders and metabolic conditions. With a total value of $2,248,158, these projects are made possible through a grant…

New Collaboration Between Saguaro Biosciences and A Leading Global Pharmaceutical Company to Enhance Drug Discovery With Live Cell Painting Technology

— Project funded through CQDM Quantum Leap program — Montréal, QUÉBEC, November 11, 2025 – CQDM and Saguaro Biosciences are proud to announce that the company has received more than $780,000 to further enhance ChromaLIVETM, the leading image-based profiling technology for AI-enabled drug discovery. ChromaLIVETM is a non-toxic and multichromatic dye that allows the generation…